Selank is a synthetic heptapeptide based on the immunomodulatory tetrapeptide tuftsin, extended for stability. It is studied as a regulatory-signaling and neuro-research tool, and its proposed mechanism reflects its origin in an immunopeptide combined with observed neuromodulatory activity in model systems.
Tuftsin-derived signaling
Because it derives from tuftsin, Selank is examined for proposed regulatory activity, with research interest spanning neuromodulatory and immunoregulatory readouts in model systems. Its mechanism is distinct from the ACTH-derived Semax, though the two are often studied together as a related pair to contrast their pathways.
Neuromodulatory readouts
In preclinical model systems, Selank has been examined for proposed influence on regulatory neuropeptide systems and on markers associated with neurotransmitter balance. These observations are made under controlled assay conditions and describe model behavior rather than physiological outcomes.
Stability by design
The added C-terminal residues are proposed to slow enzymatic degradation, giving Selank a longer usable window than native tuftsin. This durability is a key reason the peptide is tractable for research, and its short sequence follows general amino acid sequence principles. The structural basis is covered in its chemistry article.
Interpreting results
In-vitro concentrations are set by assay design, not human dosing, and receptor- or pathway-level observations do not translate to applied effects. Foundational context is in the Selank overview, with purity context in understanding HPLC purity.
No single established receptor model
Unlike peptides with one well-defined cognate receptor, Selank is generally discussed through proposed pathway-level effects rather than a universally accepted single receptor target. Reports involving neurotransmitter-related, gene-expression, or immune readouts therefore should not be collapsed into one definitive mechanism. They represent hypotheses that require confirmation with target-specific tools.
Mechanistic controls
Useful experiments pair phenotypic observations with proximal molecular measurements and include inactive-sequence or parent-fragment comparators where feasible. Time-course studies can distinguish an immediate signaling event from later transcriptional changes. Researchers should also account for peptide degradation in the assay, since the intact heptapeptide and any fragments may not produce identical readouts.
Evidence hierarchy
A useful evidence hierarchy begins with chemical integrity and peptide stability, proceeds through proximal molecular measurements, and ends with later cellular or behavioral phenotypes. Concordance across those levels strengthens a proposed pathway, while disagreement identifies where further target-validation experiments are needed.
Product page: Selank research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.